Held at Belgrade Waterfront, this year's AskGamblers Awards combined a Charity Night, a padel tournament, and a gala ceremony celebrating the standout brands and professionals of 2025. BELGRADE,...

More than 60 athletes earned qualification to the Games of the Future 2026 after five days of high-stakes phygital competition in Astana, where physical performance and gaming skill combined...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces poster presentations for CT0596 (an allogeneic CAR T-cell...

BRUIN CLL-322 is the first Phase 3 study to demonstrate superiority over a venetoclax-containing control arm in CLL, and, with the majority of patients previously treated with a covalent BTK...

Once-in-a-generation celebration will feature never-before-seen immersive experiences, 1,000 Bells of Freedom, seven celebration areas, four live stages, open bars, exquisite cuisine, and...

In the news release, LEOTEK Demonstrates Physical AI for Safer and Smarter Roadways at ITS America 2026, issued 12-Jun-2026 by LEOTEK over PR Newswire, we are advised by the company that the photo...

The United States is projected to face a shortage of 950 FTE urologists in 2026, a gap that is expected to more than double over the next decade. To better understand the factors contributing to...

Braeburn today announced it will present two oral presentations and two posters at the 88th Annual Scientific Meeting of the College on Problems of Drug Dependence (CPDD), taking place June...

GELITA, a global leader in collagen protein solutions, will showcase its latest excipient technology at BIO International 2026 in San Diego. Known for its expertise in gelatin and collagen...

AbbVie (NYSE: ABBV) today announced new Phase 3 data on a fixed-duration venetoclax-based combination at the European Hematology Association (EHA) 2026 Congress taking place June 11-14 in...